DNB Asset Management AS increased its stake in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 9.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,329,788 shares of the enterprise software provider’s stock after acquiring an additional 116,742 shares during the period. Oracle makes up about 0.9% of DNB Asset Management AS’s investment portfolio, making the stock its 17th largest position. DNB Asset Management AS’s holdings in Oracle were worth $259,189,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in ORCL. FSA Wealth Management LLC purchased a new stake in Oracle in the 3rd quarter valued at approximately $28,000. Mpwm Advisory Solutions LLC boosted its holdings in Oracle by 76.9% in the 3rd quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Turning Point Benefit Group Inc. purchased a new stake in Oracle in the 3rd quarter valued at approximately $35,000. HFM Investment Advisors LLC boosted its holdings in Oracle by 290.9% in the 4th quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock valued at $25,000 after purchasing an additional 96 shares in the last quarter. Finally, Collier Financial purchased a new stake in Oracle in the 3rd quarter valued at approximately $38,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.
Analysts Set New Price Targets
ORCL has been the topic of a number of analyst reports. Wedbush lifted their price objective on Oracle from $225.00 to $275.00 and gave the company an “outperform” rating in a report on Wednesday. Guggenheim reaffirmed a “buy” rating and issued a $400.00 price objective on shares of Oracle in a report on Friday, March 13th. Piper Sandler lowered their price objective on Oracle from $240.00 to $210.00 and set an “overweight” rating on the stock in a report on Wednesday, March 11th. Oppenheimer lifted their price objective on Oracle from $210.00 to $235.00 and gave the company an “outperform” rating in a report on Tuesday. Finally, Citigroup lifted their price objective on Oracle from $310.00 to $320.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Three analysts have rated the stock with a Strong Buy rating, twenty-nine have issued a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Oracle presently has a consensus rating of “Moderate Buy” and a consensus target price of $261.46.
Oracle Trading Down 1.3%
Shares of Oracle stock opened at $193.13 on Friday. The company has a debt-to-equity ratio of 3.66, a current ratio of 1.35 and a quick ratio of 1.35. Oracle Corporation has a 1 year low of $134.57 and a 1 year high of $345.72. The company has a market capitalization of $555.44 billion, a P/E ratio of 34.67, a P/E/G ratio of 1.87 and a beta of 1.55. The business has a 50 day moving average price of $162.96 and a 200 day moving average price of $182.92.
Oracle (NYSE:ORCL – Get Free Report) last issued its quarterly earnings data on Tuesday, March 10th. The enterprise software provider reported $1.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.08. Oracle had a return on equity of 62.70% and a net margin of 25.30%.The firm had revenue of $17.19 billion during the quarter, compared to the consensus estimate of $16.91 billion. During the same period in the previous year, the firm posted $1.47 EPS. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. Oracle has set its Q4 2026 guidance at 1.960-2.000 EPS. Sell-side analysts anticipate that Oracle Corporation will post 6.08 EPS for the current fiscal year.
Oracle Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Thursday, April 9th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Thursday, April 9th. Oracle’s payout ratio is currently 35.91%.
Insider Activity
In related news, EVP Stuart Levey sold 15,000 shares of Oracle stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the completion of the transaction, the executive vice president directly owned 3,429 shares in the company, valued at $604,155.51. The trade was a 81.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is owned by corporate insiders.
Key Headlines Impacting Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: 24/7 Wall St. reiterated a bullish view on Oracle (ORCL), setting a 12-month price target of about $245 and pointing to strong backlog growth and accelerating cloud infrastructure economics as key upside drivers.
- Positive Sentiment: Wedbush said Oracle is building a durable position for the next phase of the AI cycle, suggesting the market may be underestimating its role in future AI demand.
- Positive Sentiment: Coverage focused on Oracle’s “AI heavyweight” status as investors increasingly view its legacy software base, cloud expansion, and AI infrastructure exposure as a major advantage. Oracle Went From Tech Dinosaur to AI Heavyweight
- Positive Sentiment: Oracle also drew attention for expanding its agentic AI push through U.S. defense partnerships, reinforcing the idea that its AI platform is gaining traction in high-value government and enterprise use cases. Oracle Expands Its Agentic AI Push Through U.S. Defense Partnerships
- Neutral Sentiment: Oracle added Cleveland Clinic CEO Tomislav Mihaljevic to its board, which may support its healthcare strategy but is unlikely to be an immediate stock-moving catalyst. Oracle adds Cleveland Clinic CEO to board of directors
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Stories
- Five stocks we like better than Oracle
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
